flow semaglutide trial kidney outcomes 2024 Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial In the FLOW trial, researchers

Regular follow-ups will track progress and adjust treatment as needed

The growth-promoting effects of growth hormone include muscle tissue hypertrophy (which may be desired by some but represents an anabolic effect), bone growth and remodeling (problematic after growth plates close), organ enlargement with chronic supraphysiologic doses (cardiac hypertrophy, acromegaly features), connective tissue proliferation (potentially contributing to joint pain and carpal tunnel syndrome), and cellular proliferation that may support tumor growth in susceptible individuals

Some patients will experience symptoms like: Nausea Diarrhea Stomach pain Vomiting These side effects are likely to resolve on their own as treatment progresses

After : Drink plenty of water to help flush out toxins, and avoid alcohol or heavy meals

Antiemetic medications may be considered for persistent nausea, but domperidone should not exceed 7 days due to cardiac risks, and metoclopramide should not exceed 5 days